Prognostic relevance of circulating angiogenic cytokines basic fibroblast growth factor (FGF-2), hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) in patients with multiple myeloma.

被引：0
|
作者：
Jakob, C [1 ]
Fleissner, C [1 ]
Zavrski, I [1 ]
Heider, U [1 ]
Schulz, CO [1 ]
Langelotz, C [1 ]
Schweigert, M [1 ]
Eucker, J [1 ]
Possinger, K [1 ]
Sezer, O [1 ]
机构：
[1] Univ Hosp Berlin, Charite, Dept Hematol & Oncol, Berlin, Germany
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5048
引用
收藏
页码：372B / 372B
页数：1
相关论文
共 50 条
  • [1] Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma.
    Sezer, O
    Jakob, C
    Eucker, J
    Niemöller, K
    Schweigert, M
    Possinger, K
    [J]. BLOOD, 2000, 96 (11) : 366A - 366A
  • [2] Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma
    Sezer, O
    Jakob, C
    Eucker, J
    Niemöller, K
    Gatz, F
    Wernecke, KD
    Possinger, K
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2001, 66 (02) : 83 - 88
  • [3] Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects
    Li, Dong
    Xie, Kun
    Zhang, Longzhen
    Yao, Xuejing
    Li, Hongwen
    Xu, Qiaoyu
    Wang, Xin
    Jiang, Jing
    Fang, Jianmin
    [J]. CANCER LETTERS, 2016, 377 (02) : 164 - 173
  • [4] Autocrine regulation of vascular endothelial growth factor (VEGF) expression by fibroblast growth factor-2 (FGF-2).
    Seghezzi, G
    Patel, S
    Pintucci, G
    Galloway, A
    Rifkin, D
    Mignatti, P
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 2045 - 2045
  • [5] Longitudinal study of serum vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and syndecan-1 in patients with multiple myeloma.
    Kyrtsonis, MC
    Siakantaris, MP
    Vassilakopoulos, TP
    Kokoris, SL
    Giannakakis, A
    Angelopoulou, MK
    Pangalis, GA
    [J]. BLOOD, 2001, 98 (11) : 299B - 299B
  • [6] Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma
    M. Alexandrakis
    F. Passam
    A. Boula
    A. Christophoridou
    G. Aloizos
    P. Roussou
    D. Kyriakou
    [J]. Annals of Hematology, 2003, 82 : 19 - 23
  • [7] Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma
    Alexandrakis, MG
    Passam, FH
    Boula, A
    Christophoridou, A
    Aloizos, G
    Roussou, P
    Kyriakou, DS
    [J]. ANNALS OF HEMATOLOGY, 2003, 82 (01) : 19 - 23
  • [8] Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients
    LY Dirix
    PB Vermeulen
    A Pawinski
    A Prové
    I Benoy
    C De Pooter
    M Martin
    AT Van Oosterom
    [J]. British Journal of Cancer, 1997, 76 : 238 - 243
  • [9] Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients
    Dirix, LY
    Vermeulen, PB
    Pawinski, A
    Prove, A
    Benoy, I
    DePooter, C
    Martin, M
    VanOosterom, AT
    [J]. BRITISH JOURNAL OF CANCER, 1997, 76 (02) : 238 - 243
  • [10] Tissue factor is an angiogenic mediator that induces both vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF)
    Lee, Jung A.
    Park, Jae Eun
    Hwang, Sewook
    Lee, Do Hee
    Park, Sung Goo
    Park, Byoung Chul
    Cho, Sayeon
    [J]. BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2006, 27 (09) : 1456 - 1458
12345